Search research articles
Contact Us
Filters
Showing results (51-60 of 71) with videos related to
Page
of 8
Sort By:
Antimicrobial Agents and Chemotherapy
|
September 23, 2024
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084
Mark A Marzinke, Kelong Han, Brett Hanscom, et al.
The Journal of Infectious Diseases
|
October 14, 2022
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
Susan H Eshleman, Jessica M Fogel, Elias K Halvas, et al.
JAMA Network Open
|
February 5, 2026
Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs
Nabila El-Bassel, Steven Shoptaw, Timothy Skalland, et al.
Plos One
|
October 11, 2019
HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074
Philip J Palumbo, Yinfeng Zhang, Jessica M Fogel, et al.
The New England Journal of Medicine
|
June 1, 2007
Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis
James N Weinstein, Jon D Lurie, Tor D Tosteson, et al.
The Journal of Infectious Diseases
|
November 8, 2025
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
Brett Hanscom, Mark A Marzinke, Xinnong Li, et al.
Journal of the International AIDS Society
|
October 31, 2025
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084
Mark A Marzinke, Brett Hanscom, Daniel Haines, et al.
AIDS (London, England)
|
November 30, 2020
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs
Oleksandr Zeziulin, Katie R Mollan, Bonnie E Shook-Sa, et al.
Journal of the International AIDS Society
|
January 3, 2025
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084
Sinead Delany-Moretlwe, Brett Hanscom, Xu Guo, et al.
AIDS Research and Human Retroviruses
|
October 28, 2024
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084
Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 71) with videos related to
Sort By:
Page
of 8
Antimicrobial Agents and Chemotherapy
|
September 23, 2024
Pharmacologic evaluation of delayed long-acting cabotegravir administration among cisgender women in HPTN 084
Mark A Marzinke, Kelong Han, Brett Hanscom, et al.
The Journal of Infectious Diseases
|
October 14, 2022
HIV RNA Screening Reduces Integrase Strand Transfer Inhibitor Resistance Risk in Persons Receiving Long-Acting Cabotegravir for HIV Prevention
Susan H Eshleman, Jessica M Fogel, Elias K Halvas, et al.
JAMA Network Open
|
February 5, 2026
Prevalence of Illicit Drug Detection in 5 US Cities Among Out-of-Treatment People Who Inject Drugs
Nabila El-Bassel, Steven Shoptaw, Timothy Skalland, et al.
Plos One
|
October 11, 2019
HIV drug resistance in persons who inject drugs enrolled in an HIV prevention trial in Indonesia, Ukraine, and Vietnam: HPTN 074
Philip J Palumbo, Yinfeng Zhang, Jessica M Fogel, et al.
The New England Journal of Medicine
|
June 1, 2007
Surgical versus nonsurgical treatment for lumbar degenerative spondylolisthesis
James N Weinstein, Jon D Lurie, Tor D Tosteson, et al.
The Journal of Infectious Diseases
|
November 8, 2025
Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083
Brett Hanscom, Mark A Marzinke, Xinnong Li, et al.
Journal of the International AIDS Society
|
October 31, 2025
Evaluation of pharmacokinetic interactions between long-acting cabotegravir or emtricitabine/tenofovir disoproxil fumarate and hormonal contraceptive agents: a tertiary analysis of South African participants in HPTN 084
Mark A Marzinke, Brett Hanscom, Daniel Haines, et al.
AIDS (London, England)
|
November 30, 2020
Depressive symptoms and use of HIV care and medication-assisted treatment among people with HIV who inject drugs
Oleksandr Zeziulin, Katie R Mollan, Bonnie E Shook-Sa, et al.
Journal of the International AIDS Society
|
January 3, 2025
Evaluation of long-acting cabotegravir safety and pharmacokinetics in pregnant women in eastern and southern Africa: a secondary analysis of HPTN 084
Sinead Delany-Moretlwe, Brett Hanscom, Xu Guo, et al.
AIDS Research and Human Retroviruses
|
October 28, 2024
HIV DNA Levels in Persons Who Acquired HIV in the Setting of Long-Acting Cabotegravir for HIV Prevention: Analysis of Cases from HPTN 083 and 084
Jessica M Fogel, Deborah Persaud, Estelle Piwowar-Manning, et al.
Page
of 8